| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 22, 2023 | ETST Earth Science Tech, Inc. | Saumat Giorgio R. | CEO | Buy | 85,100 | $0.08 | $6,607.50 | - | - | - | |
| Nov 21, 2023 | ZTS Zoetis Inc. | Peck Kristin C66 | Chief Executive Officer | Sell | 13,000 | $176.84 | $2,298,856.08 | -9.7% | +4.4% | -1.7% | |
| Nov 21, 2023 | HIMS Hims & Hers Health, Inc. | Okupe Oluyemi55 | Chief Financial Officer | Sell | 6,698 | $7.62 | $51,010.29 | -2.2% | +26.8% | +187.5% | |
| Nov 21, 2023 | ETST Earth Science Tech, Inc. | Saumat Giorgio R. | CEO | Buy | 76,100 | $0.07 | $5,420.88 | - | - | - | |
| Nov 20, 2023 | BMY Bristol Myers Squibb Co | Samuels Theodore R. II51 | Director | Buy | 8,500 | $49.81 | $423,385.00 | +31.5% | +2.0% | +19.1% | |
| Nov 20, 2023 | CGC Canopy Growth Corp | Schmeling Judy56 | Director | Sell | 18,481 | $0.81 | $14,969.61 | -4.2% | -40.0% | -35.1% | |
| Nov 20, 2023 | TSNDF Terrascend Corp. | Jw Asset Management, LLC65 | Executive Chairman | Buy | 12,000 | $1.49 | $17,913.60 | - | - | - | |
| Nov 20, 2023 | CGC Canopy Growth Corp | Lazzarato David Angelo75 | Director | Sell | 38,502 | $0.81 | $31,186.62 | -15.6% | -40.0% | -35.1% | |
| Nov 20, 2023 | CGC Canopy Growth Corp | Yanofsky Theresa75 | Director | Sell | 38,344 | $0.81 | $31,058.64 | -15.3% | -40.0% | -35.1% | |
| Nov 20, 2023 | IRWD Ironwood Pharmaceuticals Inc | Davis Andrew73 | SVP, Chief Business Officer | Sell | 3,287 | $9.69 | $31,851.03 | -1.5% | +55.9% | -59.9% | |
| Nov 17, 2023 | TSNDF Terrascend Corp. | Jw Asset Management, LLC65 | Executive Chairman | Buy | 18,200 | $1.51 | $27,571.18 | - | - | - | |
| Nov 17, 2023 | ZTS Zoetis Inc. | Lagano Roxanne70 | Executive Vice President | Sell | 923 | $177.46 | $163,795.58 | -3.9% | +8.5% | +0.2% | |
| Nov 17, 2023 | ANIP Ani Pharmaceuticals Inc | Shanmugam Muthusamy59 | Head Of R&D, Coo-novitium Ops | Sell | 13,000 | $51.00 | $663,000.00 | -1.3% | +12.0% | +10.1% | |
| Nov 17, 2023 | AMPH Amphastar Pharmaceuticals, Inc. | Prins Richard K61 | Director | Sell | 4,000 | $55.86 | $223,445.60 | -11.1% | -0.6% | -20.1% | |
| Nov 16, 2023 | LNTH Lantheus Holdings, Inc. | Blanchfield Paul54 | President | Sell | 1,500 | $67.96 | $101,940.00 | -1.7% | -17.3% | +12.7% | |
| Nov 16, 2023 | UTHR United Therapeutics Corp | Mahon Paul A47 | EVP &General Counsel | Sell | 6,000 | $226.60 | $1,359,592.76 | -3.8% | -5.4% | +60.3% | |
| Nov 16, 2023 | HROW Harrow, Inc. | Baum Mark L66 | Chief Executive Officer | Buy | 7,500 | $8.11 | $60,825.00 | +0.4% | +33.6% | +353.6% | |
| Nov 16, 2023 | ETST Earth Science Tech, Inc. | Saumat Giorgio R. | CEO | Buy | 55,000 | $0.08 | $4,125.00 | - | - | - | |
| Nov 16, 2023 | SUPN Supernus Pharmaceuticals, Inc. | Newhall Charles W III | Director | Sell | 2,500 | $28.01 | $70,025.00 | -2.1% | -1.1% | +27.6% | |
| Nov 16, 2023 | PRGO Perrigo Co Plc | Ives Alison57 | EVP &Chief Scientific Officer | Buy | 2,040 | $29.34 | $59,853.60 | +24.5% | +8.0% | -8.2% | |
| Nov 16, 2023 | ANIP Ani Pharmaceuticals Inc | Shanmugam Muthusamy59 | Head Of R&D, Coo-novitium Ops | Sell | 36,190 | $53.00 | $1,918,079.91 | -1.2% | +9.5% | +10.4% | |
| Nov 15, 2023 | SUPN Supernus Pharmaceuticals, Inc. | Hudson Frederick M. | Director | Sell | 9,093 | $28.50 | $259,150.50 | -11.3% | -5.2% | +26.5% | |
| Nov 15, 2023 | TSNDF Terrascend Corp. | Jw Asset Management, LLC65 | Executive Chairman | Buy | 15,000 | $1.56 | $23,367.00 | - | - | - | |
| Nov 15, 2023 | ANIP Ani Pharmaceuticals Inc | Davis Krista45 | SVP, Chief Hr Officer | Sell | 2,622 | $53.81 | $141,089.82 | -7.4% | +5.2% | +12.6% | |
| Nov 15, 2023 | ETST Earth Science Tech, Inc. | Saumat Giorgio R. | CEO | Buy | 35,000 | $0.07 | $2,450.00 | - | - | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.